1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Wu, K.P. Wu, C.W. Tsao, Y.P. Lou, Y.C. Lin, C.W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 278 46007 46013 10.1074/jbc.M307776200 12952958 Structural Basis of a Flavivirus Recognized by Its Neutralizing Antibody: SOLUTION STRUCTURE OF THE DOMAIN III OF THE JAPANESE ENCEPHALITIS VIRUS ENVELOPE PROTEIN. 2003 10.2210/pdb1pjw/pdb pdb_00001pjw 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 11769.368 envelope protein Domain III 1 man polymer no no DKLALKGTTYGMCTEKFSFAKNPADTGHGTVVIELSYSGSDGPCKIPIVSVASLNDMTPVGRLVTVNPFVATSSANSKVL VEMEPPFGDSYIVVGMGDKQINHHWHKAGST DKLALKGTTYGMCTEKFSFAKNPADTGHGTVVIELSYSGSDGPCKIPIVSVASLNDMTPVGRLVTVNPFVATSSANSKVL VEMEPPFGDSYIVVGMGDKQINHHWHKAGST A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Flavivirus Escherichia Escherichia coli sample 11072 Japanese encephalitis virus 511693 Escherichia coli BL21 BL21 PLASMID PET22b database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-11-25 1 1 2008-04-29 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name RCSB Y PDBJ 2003-06-04 REL REL The structure was determined using triple-resonance NMR spectroscopy. structures with acceptable covalent geometry, structures with favorable non-bond energy, structures with the least restraint violations, structures with the lowest energy 100 15 2D NOESY 2D TOCSY 3D_15N-separated_NOESY 3D_13C-separated_NOESY HNHA 7.5 ambient 308 K The structures are based on a total of 957 restraints, 717 are NOE-derived distance constraints, 194 dihedral angle restraints,46 distance restraints from hydrogen bonds. simulated annealing 1 lowest energy 2.3mM JEV domain III protein, N15-C13 labled and N15-labled, 136mM NaCl, 2.68mM KCl, 10mM Na2HPO4, 1.76mM KH2PO4 90% H2O/10% D2O Bo Blanton collection XwinNMR 2.6 Peter Neidig processing AURELIA 2.1 Delaglio F. data analysis NMRPipe Brunger structure solution X-PLOR 3.851 refinement X-PLOR 3.851 600 Bruker DMX ASP 1 n 1 ASP 1 A LYS 2 n 2 LYS 2 A LEU 3 n 3 LEU 3 A ALA 4 n 4 ALA 4 A LEU 5 n 5 LEU 5 A LYS 6 n 6 LYS 6 A GLY 7 n 7 GLY 7 A THR 8 n 8 THR 8 A THR 9 n 9 THR 9 A TYR 10 n 10 TYR 10 A GLY 11 n 11 GLY 11 A MET 12 n 12 MET 12 A CYS 13 n 13 CYS 13 A THR 14 n 14 THR 14 A GLU 15 n 15 GLU 15 A LYS 16 n 16 LYS 16 A PHE 17 n 17 PHE 17 A SER 18 n 18 SER 18 A PHE 19 n 19 PHE 19 A ALA 20 n 20 ALA 20 A LYS 21 n 21 LYS 21 A ASN 22 n 22 ASN 22 A PRO 23 n 23 PRO 23 A ALA 24 n 24 ALA 24 A ASP 25 n 25 ASP 25 A THR 26 n 26 THR 26 A GLY 27 n 27 GLY 27 A HIS 28 n 28 HIS 28 A GLY 29 n 29 GLY 29 A THR 30 n 30 THR 30 A VAL 31 n 31 VAL 31 A VAL 32 n 32 VAL 32 A ILE 33 n 33 ILE 33 A GLU 34 n 34 GLU 34 A LEU 35 n 35 LEU 35 A SER 36 n 36 SER 36 A TYR 37 n 37 TYR 37 A SER 38 n 38 SER 38 A GLY 39 n 39 GLY 39 A SER 40 n 40 SER 40 A ASP 41 n 41 ASP 41 A GLY 42 n 42 GLY 42 A PRO 43 n 43 PRO 43 A CYS 44 n 44 CYS 44 A LYS 45 n 45 LYS 45 A ILE 46 n 46 ILE 46 A PRO 47 n 47 PRO 47 A ILE 48 n 48 ILE 48 A VAL 49 n 49 VAL 49 A SER 50 n 50 SER 50 A VAL 51 n 51 VAL 51 A ALA 52 n 52 ALA 52 A SER 53 n 53 SER 53 A LEU 54 n 54 LEU 54 A ASN 55 n 55 ASN 55 A ASP 56 n 56 ASP 56 A MET 57 n 57 MET 57 A THR 58 n 58 THR 58 A PRO 59 n 59 PRO 59 A VAL 60 n 60 VAL 60 A GLY 61 n 61 GLY 61 A ARG 62 n 62 ARG 62 A LEU 63 n 63 LEU 63 A VAL 64 n 64 VAL 64 A THR 65 n 65 THR 65 A VAL 66 n 66 VAL 66 A ASN 67 n 67 ASN 67 A PRO 68 n 68 PRO 68 A PHE 69 n 69 PHE 69 A VAL 70 n 70 VAL 70 A ALA 71 n 71 ALA 71 A THR 72 n 72 THR 72 A SER 73 n 73 SER 73 A SER 74 n 74 SER 74 A ALA 75 n 75 ALA 75 A ASN 76 n 76 ASN 76 A SER 77 n 77 SER 77 A LYS 78 n 78 LYS 78 A VAL 79 n 79 VAL 79 A LEU 80 n 80 LEU 80 A VAL 81 n 81 VAL 81 A GLU 82 n 82 GLU 82 A MET 83 n 83 MET 83 A GLU 84 n 84 GLU 84 A PRO 85 n 85 PRO 85 A PRO 86 n 86 PRO 86 A PHE 87 n 87 PHE 87 A GLY 88 n 88 GLY 88 A ASP 89 n 89 ASP 89 A SER 90 n 90 SER 90 A TYR 91 n 91 TYR 91 A ILE 92 n 92 ILE 92 A VAL 93 n 93 VAL 93 A VAL 94 n 94 VAL 94 A GLY 95 n 95 GLY 95 A MET 96 n 96 MET 96 A GLY 97 n 97 GLY 97 A ASP 98 n 98 ASP 98 A LYS 99 n 99 LYS 99 A GLN 100 n 100 GLN 100 A ILE 101 n 101 ILE 101 A ASN 102 n 102 ASN 102 A HIS 103 n 103 HIS 103 A HIS 104 n 104 HIS 104 A TRP 105 n 105 TRP 105 A HIS 106 n 106 HIS 106 A LYS 107 n 107 LYS 107 A ALA 108 n 108 ALA 108 A GLY 109 n 109 GLY 109 A SER 110 n 110 SER 110 A THR 111 n 111 THR 111 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ALA 24 A N ALA 24 A O VAL 32 A O VAL 32 A N ILE 33 A N ILE 33 A O VAL 81 A O VAL 81 A N VAL 51 A N VAL 51 A O TYR 91 A O TYR 91 A N ILE 92 A N ILE 92 A O HIS 103 A O HIS 103 1 A A H O THR THR 26 30 1.60 2 A A H O SER ASP 53 89 1.59 5 A A H O ILE PRO 46 68 1.59 7 A A H O SER ASP 53 89 1.60 8 A A H O SER ASP 53 89 1.51 9 A A H O SER ASP 53 89 1.54 9 A A H O THR THR 26 30 1.60 11 A A H O ILE PRO 46 68 1.55 11 A A HH O TYR GLY 37 42 1.56 13 A A H O SER ASP 53 89 1.47 14 A A H O SER ASP 53 89 1.57 1 A ARG 62 0.241 SIDE CHAIN 3 A ARG 62 0.208 SIDE CHAIN 4 A ARG 62 0.236 SIDE CHAIN 5 A ARG 62 0.307 SIDE CHAIN 6 A ARG 62 0.175 SIDE CHAIN 7 A ARG 62 0.314 SIDE CHAIN 8 A ARG 62 0.301 SIDE CHAIN 9 A ARG 62 0.296 SIDE CHAIN 10 A ARG 62 0.303 SIDE CHAIN 11 A ARG 62 0.215 SIDE CHAIN 13 A ARG 62 0.249 SIDE CHAIN 14 A ARG 62 0.260 SIDE CHAIN 15 A ARG 62 0.278 SIDE CHAIN 1 A THR 9 -47.56 109.43 1 A THR 14 -161.56 41.96 1 A LEU 54 81.47 29.96 1 A VAL 60 -143.89 -49.08 1 A VAL 66 -44.65 170.68 1 A ASN 67 -47.08 157.70 1 A LYS 78 -62.87 88.86 1 A GLU 84 -113.43 62.87 1 A MET 96 -108.38 -150.77 1 A ASP 98 -74.98 -105.67 1 A ALA 108 179.76 152.36 2 A LYS 6 -106.66 -164.03 2 A THR 14 -160.84 42.12 2 A LEU 54 81.17 29.55 2 A VAL 60 -139.20 -36.22 2 A VAL 66 -47.16 173.30 2 A LYS 78 -63.21 88.06 2 A GLU 84 -117.95 68.56 2 A ASP 98 -64.00 -108.41 2 A ALA 108 -172.69 131.06 3 A TYR 10 -46.79 174.47 3 A THR 14 -161.43 44.04 3 A LYS 16 -111.48 61.85 3 A LEU 54 79.53 30.51 3 A VAL 60 -148.24 -37.37 3 A VAL 66 -55.07 -170.61 3 A LYS 78 -64.34 89.56 3 A GLU 84 -118.07 70.05 3 A ASP 98 -71.14 -75.58 3 A ALA 108 179.73 141.14 4 A THR 9 -46.67 155.42 4 A THR 14 -158.24 -76.55 4 A LYS 16 -56.04 81.97 4 A LEU 54 77.21 30.76 4 A VAL 60 -143.86 -36.41 4 A VAL 66 -57.92 -175.02 4 A ASN 67 -46.93 156.91 4 A ALA 71 -66.09 65.01 4 A LYS 78 -62.96 88.33 4 A GLU 84 -106.57 72.72 4 A ASP 98 -65.97 -82.82 4 A SER 110 -65.15 -150.47 5 A LEU 5 -103.71 73.98 5 A THR 9 -114.26 76.30 5 A THR 14 -160.54 61.70 5 A LEU 54 80.07 30.39 5 A VAL 60 -133.83 -59.42 5 A VAL 66 -44.34 171.25 5 A ASN 67 -46.86 162.20 5 A LYS 78 -63.92 89.11 5 A GLU 84 -106.13 73.96 5 A PHE 87 -53.71 103.49 5 A TRP 105 -58.06 93.59 6 A THR 14 -161.32 51.16 6 A LYS 16 -101.48 61.29 6 A PHE 19 -59.02 107.94 6 A LEU 54 79.72 30.49 6 A VAL 60 -148.07 -33.67 6 A VAL 66 -58.14 176.16 6 A LYS 78 -63.19 88.62 6 A MET 96 -98.36 -71.41 6 A ASP 98 -162.18 -46.96 6 A SER 110 -141.65 43.30 7 A LYS 6 -120.28 -165.12 7 A THR 14 -161.75 35.84 7 A SER 40 -82.95 31.08 7 A LEU 54 78.32 30.56 7 A VAL 60 -139.31 -46.87 7 A VAL 66 -54.76 -172.74 7 A VAL 70 -103.69 60.26 7 A ALA 71 -69.67 57.86 7 A LYS 78 -63.70 88.38 7 A ASP 98 -82.38 -77.61 7 A ALA 108 -174.57 111.94 8 A THR 14 -160.76 31.80 8 A LEU 54 170.68 -61.67 8 A VAL 60 -135.02 -47.77 8 A VAL 66 -50.99 179.99 8 A LYS 78 -62.91 88.72 8 A GLU 84 -115.86 57.05 8 A ASP 98 -160.56 -50.91 9 A THR 14 -161.58 53.95 9 A PHE 19 -60.97 96.87 9 A LEU 54 87.18 29.27 9 A VAL 60 -131.45 -33.72 9 A VAL 66 -59.15 -170.74 9 A LYS 78 -62.79 87.94 9 A GLU 84 -106.93 74.87 9 A MET 96 -115.74 70.07 9 A ASP 98 -149.36 -88.10 9 A SER 110 -174.70 -33.79 10 A LEU 5 -110.95 62.58 10 A THR 14 -161.98 35.63 10 A GLU 15 -68.25 3.51 10 A LYS 16 -105.18 60.55 10 A PHE 19 -56.02 97.10 10 A LEU 54 117.69 19.61 10 A VAL 60 -137.86 -42.32 10 A VAL 66 -53.40 179.34 10 A LYS 78 -62.86 90.48 10 A GLU 84 -114.46 59.30 10 A ASP 98 -81.39 -70.16 11 A THR 9 -45.44 95.60 11 A THR 14 -162.93 19.54 11 A THR 26 -134.24 -45.55 11 A LEU 54 78.72 30.24 11 A VAL 60 -135.12 -43.66 11 A VAL 66 -52.87 -170.48 11 A LYS 78 -63.44 88.83 11 A GLU 84 -109.34 75.55 11 A ASP 98 -90.60 -85.26 11 A TRP 105 -59.78 109.52 11 A SER 110 57.17 101.48 12 A THR 9 -44.64 156.37 12 A THR 14 -160.27 50.37 12 A GLU 15 -77.88 28.18 12 A PHE 19 -61.24 98.38 12 A LEU 54 173.19 -71.62 12 A VAL 66 -41.23 159.78 12 A ASN 67 -46.58 158.59 12 A LYS 78 -63.14 88.65 12 A GLU 84 -115.33 66.24 12 A MET 96 -153.54 13.89 12 A ASP 98 -99.44 -68.71 12 A TRP 105 -58.51 93.89 13 A THR 14 -162.25 28.90 13 A SER 53 -67.61 99.90 13 A LEU 54 172.06 -67.15 13 A VAL 60 -147.18 10.41 13 A VAL 64 -100.07 42.79 13 A VAL 66 -52.72 -171.25 13 A LYS 78 -63.16 89.03 13 A GLU 84 -110.79 67.89 13 A ASP 98 -63.75 -107.59 13 A TRP 105 -51.76 99.38 14 A TYR 10 -48.07 179.06 14 A THR 14 -162.22 25.09 14 A GLU 15 -49.78 -18.67 14 A THR 26 -100.66 -80.84 14 A LEU 54 171.00 -64.12 14 A VAL 60 -142.30 -36.35 14 A VAL 66 -44.09 168.93 14 A LYS 78 -62.98 88.47 14 A GLU 84 -109.24 76.62 14 A HIS 104 -119.34 79.92 14 A ALA 108 -47.49 154.72 14 A SER 110 -66.46 -177.22 15 A THR 9 -51.17 173.87 15 A THR 14 -161.50 62.80 15 A LEU 54 78.58 30.55 15 A VAL 60 -142.31 -31.43 15 A VAL 66 -52.23 -172.29 15 A VAL 70 -116.29 60.43 15 A LYS 78 -63.35 88.82 15 A GLU 84 -114.69 66.38 Solution Structure of the Domain III of the Japan Encephalitis Virus Envelope Protein 1 N N disulf 2.024 A CYS 13 A SG CYS 13 1_555 A CYS 44 A SG CYS 44 1_555 VIRAL PROTEIN flavivirus, JEV, E protein, epitope mapping, Viral protein Q9J0X3_9FLAV UNP 1 292 Q9J0X3 DKLALKGTTYGMCTEKFSFAKNPADTGHGTVVIELSYSGSDGPCKIPIVSVASLNDMTPVGRLVTVNPFVATSSANSKVL VEMEPPFGDSYIVVGMGDKQINHHWHKAGST 292 402 1PJW 1 111 Q9J0X3 A 1 1 111 3 3 anti-parallel anti-parallel anti-parallel anti-parallel A PHE 17 A PHE 17 A ASP 25 A ASP 25 A VAL 31 A VAL 31 A TYR 37 A TYR 37 A LYS 78 A LYS 78 A MET 83 A MET 83 A ILE 48 A ILE 48 A ALA 52 A ALA 52 A SER 90 A SER 90 A GLY 95 A GLY 95 A GLN 100 A GLN 100 A TRP 105 A TRP 105